bf/NASDAQ:FENC_icon.jpeg

NASDAQ:FENC

Fennec Pharmaceuticals Inc.

  • Stock

USD

Last Close

8.00

06/11 21:00

Market Cap

163.93M

Beta: 0.16

Volume Today

65.31K

Avg: 80.91K

PE Ratio

−11.72

PFCF: −16.43

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
Dec '24
revenue
170K
-
1.53M
-
21.64M
1,309.89%
47.54M
119.66%
cost of revenue
86K
-
1.28M
1,390.80%
3.18M
148.34%
gross profit
170K
-
1.45M
-
20.36M
1,305.08%
44.35M
117.85%
selling and marketing expenses
2.79M
-
18.43M
-
general and administrative expenses
2.52M
-
1.63M
35.16%
2.40M
46.82%
5.01M
109.05%
5.40M
7.70%
7.40M
37.05%
12.95M
74.95%
12.24M
5.47%
17.72M
44.76%
23.05M
-
selling general and administrative expenses
2.52M
-
1.63M
35.16%
2.40M
46.82%
5.01M
109.05%
5.40M
7.70%
7.40M
37.05%
12.95M
74.95%
12.24M
5.47%
20.51M
67.51%
33.31M
62.42%
41.48M
24.53%
research and development expenses
357K
-
256K
28.29%
472K
84.38%
1.94M
310.17%
5.01M
158.68%
5.61M
11.96%
5.11M
8.95%
4.98M
2.43%
3.53M
29.11%
57.03K
98.38%
307K
438.35%
other expenses
-14K
-
-8K
42.86%
6K
175%
-17K
383.33%
-9K
47.06%
cost and expenses
2.88M
-
1.89M
34.31%
2.87M
51.90%
6.95M
142.11%
10.41M
49.75%
13.01M
24.98%
18.05M
38.79%
17.22M
4.61%
24.12M
40.07%
34.65M
43.62%
44.97M
29.80%
operating expenses
2.88M
-
1.89M
34.31%
2.87M
51.90%
6.95M
142.11%
10.41M
49.75%
13.01M
24.98%
18.05M
38.79%
17.22M
4.61%
24.04M
39.57%
33.36M
38.80%
41.79M
25.24%
interest expense
2K
-
126K
-
978K
676.19%
3.75M
283.28%
4.07M
8.55%
ebitda
-3.58M
-
-3.12M
12.81%
-2.96M
5.10%
-6.82M
130.38%
-10.58M
55.14%
-13.01M
23.00%
-17.98M
38.25%
-17.18M
4.45%
-22.54M
31.18%
-13.01M
42.31%
3.60M
127.68%
operating income
-2.88M
-
-1.89M
34.31%
-2.87M
51.90%
-6.95M
142.11%
-10.41M
49.75%
-13.01M
24.98%
-17.89M
37.48%
-17.22M
3.70%
-22.59M
31.16%
-13.01M
42.43%
2.57M
119.75%
depreciation and amortization
-699K
-
-1.23M
75.68%
-88K
92.83%
134K
252.27%
521K
288.81%
64K
87.72%
-100K
256.25%
38K
138%
46K
21.05%
-1
100.00%
1.03M
103,200,100%
total other income expenses net
699K
-
1.23M
75.68%
74K
93.97%
-142K
291.89%
173K
221.83%
234K
35.26%
-224K
195.73%
-123K
45.09%
-1.13M
814.63%
-3.33M
196.36%
-2.64M
20.85%
income before tax
-2.18M
-
-659K
69.72%
-2.79M
323.22%
-7.05M
152.64%
-9.89M
40.33%
-12.78M
29.20%
-18.11M
41.75%
-17.35M
4.21%
-23.71M
36.71%
-16.34M
31.10%
-71K
99.57%
income tax expense
-2K
-
-3K
50%
-8K
166.67%
-47K
487.50%
-348K
640.43%
-315K
9.48%
-187K
40.63%
110K
158.82%
1.13M
922.73%
1
100.00%
365K
36,499,900%
net income
-2.18M
-
-659K
69.72%
-2.79M
323.22%
-7.05M
152.64%
-9.89M
40.33%
-12.46M
26.01%
-17.92M
43.84%
-17.46M
2.60%
-24.84M
42.29%
-16.34M
34.22%
-436K
97.33%
weighted average shs out
9.87M
-
10.83M
9.68%
12.77M
17.90%
15.01M
17.62%
19.02M
26.65%
19.96M
4.97%
23.70M
18.75%
26.01M
9.71%
26.27M
1.03%
26.57M
1.14%
27.29M
2.71%
weighted average shs out dil
9.87M
-
10.83M
9.68%
12.77M
17.90%
15.01M
17.62%
19.02M
26.65%
19.96M
4.97%
23.70M
18.75%
26.01M
9.71%
26.27M
1.03%
26.57M
1.14%
27.29M
2.71%
eps
-0.22
-
-0.06
72.32%
-0.22
261.25%
-0.47
113.64%
-0.52
10.64%
-0.62
19.23%
-0.76
22.58%
-0.67
11.84%
-0.95
41.79%
-0.61
35.79%
-0.02
97.38%
epsdiluted
-0.22
-
-0.06
72.32%
-0.22
261.25%
-0.47
113.64%
-0.52
10.64%
-0.62
19.23%
-0.76
22.58%
-0.67
11.84%
-0.95
41.79%
-0.61
35.79%
-0.02
97.38%

All numbers in USD (except ratios and percentages)